Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells
Conditions: Retinitis Pigmentosa; Inherited Retinal Dystrophy Intervention: Biological: Wharton's jelly derived mesenchymal stem cell Sponsor: Ankara Universitesi Teknokent Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Reflex Sympathetic Dystrophy | Research | Retinitis Pigmentosa | Stem Cell Therapy | Stem Cells